The University of Chicago Header Logo

Mitchell Posner

Concepts (880)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Esophageal Neoplasms
35
2020
355
4.490
Why?
Adenocarcinoma
45
2021
1215
3.690
Why?
Stomach Neoplasms
21
2021
321
3.230
Why?
Esophagectomy
15
2019
94
2.440
Why?
Liver Neoplasms
24
2023
840
2.130
Why?
Pancreatic Neoplasms
23
2025
782
2.080
Why?
Antineoplastic Combined Chemotherapy Protocols
22
2023
2666
1.920
Why?
Surgical Oncology
4
2023
34
1.800
Why?
Hepatectomy
11
2014
218
1.750
Why?
Colorectal Neoplasms
20
2023
1120
1.500
Why?
Lymph Node Excision
9
2016
238
1.480
Why?
Neoadjuvant Therapy
12
2018
477
1.450
Why?
Pancreaticoduodenectomy
9
2019
102
1.380
Why?
Gastrectomy
10
2021
75
1.280
Why?
Carcinoma, Squamous Cell
16
2017
1107
1.130
Why?
General Surgery
5
2016
271
1.070
Why?
Combined Modality Therapy
32
2019
1754
0.960
Why?
Medical Oncology
5
2023
426
0.950
Why?
Head and Neck Neoplasms
9
2019
1091
0.920
Why?
Humans
197
2025
98799
0.890
Why?
Genetic Therapy
13
2008
374
0.840
Why?
Chemotherapy, Adjuvant
13
2017
527
0.840
Why?
Human papillomavirus 16
2
2014
46
0.740
Why?
Fellowships and Scholarships
6
2020
164
0.730
Why?
Esophagogastric Junction
2
2019
36
0.730
Why?
Carcinoma
6
2014
442
0.730
Why?
MicroRNAs
8
2023
609
0.660
Why?
Tumor Necrosis Factor-alpha
12
2012
712
0.660
Why?
Survival Rate
20
2025
2057
0.650
Why?
Laparoscopy
8
2020
800
0.640
Why?
Middle Aged
79
2025
29642
0.630
Why?
Neoplasms
19
2019
3382
0.630
Why?
Cholangiocarcinoma
3
2014
92
0.620
Why?
Male
104
2025
47475
0.620
Why?
Neoplasm Staging
23
2019
2087
0.620
Why?
Aged
70
2025
21986
0.610
Why?
Female
108
2025
51997
0.590
Why?
Rectal Neoplasms
4
2019
139
0.590
Why?
Pancreatectomy
9
2025
222
0.580
Why?
Prognosis
21
2022
4139
0.580
Why?
Neoplasm Metastasis
12
2020
1102
0.570
Why?
Metastasectomy
2
2019
9
0.560
Why?
Glucuronosyltransferase
1
2020
178
0.560
Why?
Randomized Controlled Trials as Topic
5
2017
995
0.550
Why?
Treatment Outcome
36
2020
9806
0.550
Why?
Antineoplastic Agents
17
2020
2386
0.540
Why?
Gene Expression Regulation, Neoplastic
11
2018
1400
0.520
Why?
Specialties, Surgical
6
2020
90
0.500
Why?
Awards and Prizes
2
2013
37
0.480
Why?
Fluorouracil
12
2023
543
0.480
Why?
Bile Duct Neoplasms
2
2014
106
0.470
Why?
Gastrointestinal Stromal Tumors
3
2012
23
0.460
Why?
Lymph Nodes
3
2016
563
0.460
Why?
Chemoradiotherapy, Adjuvant
1
2016
40
0.460
Why?
Education, Medical, Graduate
6
2018
455
0.450
Why?
Immediate-Early Proteins
5
2004
160
0.450
Why?
Surgical Procedures, Operative
7
2024
236
0.450
Why?
Follow-Up Studies
18
2019
4049
0.450
Why?
Specialization
1
2015
69
0.430
Why?
Pneumonia, Viral
4
2020
343
0.430
Why?
Postoperative Complications
9
2024
2719
0.430
Why?
Coronavirus Infections
4
2020
339
0.430
Why?
Accreditation
1
2015
80
0.430
Why?
Certification
1
2015
67
0.430
Why?
Digestive System Surgical Procedures
5
2019
153
0.420
Why?
Comparative Effectiveness Research
1
2015
62
0.410
Why?
Clinical Competence
8
2018
873
0.410
Why?
Carcinoma, Hepatocellular
3
2004
455
0.410
Why?
Clinical Trials as Topic
8
2020
1128
0.390
Why?
Aged, 80 and over
21
2020
7461
0.390
Why?
Gastrointestinal Neoplasms
3
2022
114
0.390
Why?
Neoplasm Recurrence, Local
14
2019
1538
0.390
Why?
Adult
52
2024
29698
0.370
Why?
Thoracotomy
2
2010
71
0.370
Why?
Societies, Medical
4
2019
687
0.360
Why?
Pandemics
5
2020
923
0.350
Why?
Sarcoma
2
2012
222
0.350
Why?
Medical Records Systems, Computerized
2
2011
40
0.350
Why?
Papillomavirus E7 Proteins
1
2011
31
0.340
Why?
Liver Transplantation
5
2016
1235
0.340
Why?
Oncogene Proteins, Viral
1
2011
34
0.340
Why?
Disease Models, Animal
9
2017
2581
0.340
Why?
Forms and Records Control
1
2011
15
0.330
Why?
Prospective Studies
15
2019
4837
0.330
Why?
Biomarkers, Tumor
5
2022
1786
0.330
Why?
Xenograft Model Antitumor Assays
11
2018
559
0.330
Why?
Barrett Esophagus
6
2014
94
0.320
Why?
Papillomavirus Infections
1
2014
311
0.320
Why?
DNA-Binding Proteins
7
2005
1275
0.320
Why?
Cancer Vaccines
2
2011
168
0.310
Why?
Betacoronavirus
4
2020
288
0.310
Why?
Piperazines
3
2012
308
0.310
Why?
Attitude of Health Personnel
1
2015
688
0.310
Why?
Radiotherapy
7
2017
325
0.310
Why?
Proteome
1
2011
165
0.300
Why?
Mice, Nude
14
2020
829
0.300
Why?
Antibodies, Viral
2
2011
342
0.290
Why?
Pyrimidines
3
2012
416
0.290
Why?
Promoter Regions, Genetic
9
2006
979
0.290
Why?
Oropharyngeal Neoplasms
1
2011
152
0.290
Why?
Cisplatin
13
2010
578
0.280
Why?
Survival Analysis
12
2017
1530
0.270
Why?
Deoxycytidine
3
2019
218
0.270
Why?
Transcription Factors
7
2005
1724
0.270
Why?
Repressor Proteins
1
2011
450
0.260
Why?
Carcinoembryonic Antigen
1
2007
40
0.260
Why?
Glycolipids
1
2007
27
0.260
Why?
Animals
44
2020
29045
0.260
Why?
Postoperative Care
5
2017
239
0.260
Why?
Transcription, Genetic
6
2009
1136
0.250
Why?
Lung Neoplasms
9
2019
2474
0.250
Why?
Chemoradiotherapy
5
2018
337
0.250
Why?
Disease-Free Survival
8
2019
1196
0.250
Why?
Induction Chemotherapy
2
2018
152
0.250
Why?
Immunotherapy
3
2016
831
0.250
Why?
Chromosomes, Human, Pair 14
2
2018
52
0.250
Why?
Glycoproteins
1
2007
222
0.240
Why?
Carcinoma, Pancreatic Ductal
2
2019
158
0.240
Why?
Rats, Inbred Strains
1
2006
300
0.240
Why?
Organoplatinum Compounds
3
2017
95
0.240
Why?
Lymphatic Metastasis
6
2014
519
0.240
Why?
Interpersonal Relations
1
2007
182
0.240
Why?
Killer Cells, Natural
2
1999
298
0.230
Why?
Retrospective Studies
18
2023
11104
0.230
Why?
Time Factors
14
2017
5586
0.230
Why?
Healthcare Disparities
2
2024
558
0.230
Why?
Apoptosis
8
2018
1754
0.220
Why?
Patient Selection
4
2020
725
0.220
Why?
Tumor Cells, Cultured
11
2018
1029
0.220
Why?
Hospitals, Low-Volume
2
2016
28
0.220
Why?
Islets of Langerhans Transplantation
2
2019
288
0.220
Why?
Genetic Vectors
8
2012
425
0.210
Why?
Nomograms
1
2025
34
0.210
Why?
Leucovorin
4
2020
205
0.210
Why?
Herpesvirus 1, Human
4
2007
210
0.210
Why?
HIV Envelope Protein gp120
8
2000
17
0.210
Why?
Patient Dropouts
1
2004
33
0.210
Why?
Models, Animal
2
2003
282
0.200
Why?
Neoplasm Transplantation
9
2016
400
0.200
Why?
Gastroenterology
2
2016
162
0.200
Why?
Mice
24
2020
12762
0.190
Why?
Quality Indicators, Health Care
2
2016
158
0.190
Why?
Laparotomy
4
2015
65
0.190
Why?
Cell Line, Tumor
15
2016
2913
0.190
Why?
Mucin-1
1
2003
46
0.190
Why?
Oncolytic Virotherapy
3
2007
36
0.190
Why?
Waiting Lists
1
2004
239
0.190
Why?
Adenoviridae
7
2007
341
0.190
Why?
Stromal Cells
1
2003
153
0.180
Why?
Radiotherapy, Adjuvant
3
2010
325
0.180
Why?
Peptide Fragments
2
2003
480
0.180
Why?
Internship and Residency
4
2018
1132
0.180
Why?
Transplantation, Heterotopic
1
2002
46
0.180
Why?
Clinical Trials, Phase III as Topic
3
2018
172
0.180
Why?
Early Growth Response Protein 1
8
2007
58
0.180
Why?
Abdominal Neoplasms
1
2002
38
0.180
Why?
Infection Control
2
2020
134
0.170
Why?
Genes, p53
3
2001
108
0.170
Why?
Endoscopy
3
2014
388
0.170
Why?
Fibrosis
1
2003
235
0.170
Why?
Esophagoscopy
2
2014
91
0.170
Why?
Genotype
4
2020
1895
0.170
Why?
User-Computer Interface
2
2020
195
0.170
Why?
HIV-1
7
2000
179
0.170
Why?
Biopsy, Needle
6
2010
225
0.170
Why?
Antibodies, Monoclonal, Humanized
2
2020
1105
0.170
Why?
Melanoma
2
1996
523
0.170
Why?
Biological Products
1
2024
191
0.170
Why?
United States
13
2025
8387
0.160
Why?
Colonic Neoplasms
4
2003
592
0.160
Why?
Mouth Neoplasms
3
2015
223
0.160
Why?
Melanoma, Experimental
3
2011
114
0.160
Why?
Tomography, X-Ray Computed
8
2019
2680
0.160
Why?
Acetophenones
1
2020
27
0.160
Why?
Circulating Tumor DNA
1
2022
82
0.160
Why?
Kidney Transplantation
2
2011
944
0.160
Why?
Biliary Tract Neoplasms
1
2000
39
0.160
Why?
Drug Resistance, Neoplasm
3
2018
671
0.160
Why?
Imatinib Mesylate
3
2012
129
0.160
Why?
Adoptive Transfer
2
1999
174
0.160
Why?
Neoplasms, Experimental
4
2016
263
0.160
Why?
Vaccination
2
2016
328
0.160
Why?
Cell-Free Nucleic Acids
1
2022
116
0.160
Why?
Transplantation Tolerance
1
2002
148
0.150
Why?
Positron-Emission Tomography
2
2020
354
0.150
Why?
Recurrence
2
2014
1274
0.150
Why?
Actomyosin
1
2020
52
0.150
Why?
Rats
10
2007
4079
0.150
Why?
Breast Neoplasms
7
2015
3303
0.150
Why?
Pneumonectomy
1
2002
222
0.150
Why?
Surgery Department, Hospital
1
2020
44
0.150
Why?
HCT116 Cells
5
2020
164
0.150
Why?
History, 20th Century
2
2013
323
0.150
Why?
Disease Transmission, Infectious
1
2020
56
0.150
Why?
Biliary Tract Surgical Procedures
2
2016
14
0.150
Why?
Erlotinib Hydrochloride
1
2019
88
0.150
Why?
Personnel Selection
1
2020
67
0.150
Why?
Health Resources
1
2020
80
0.150
Why?
Benzamides
3
2012
260
0.150
Why?
Cytoskeleton
1
2020
201
0.150
Why?
Guidelines as Topic
2
2018
169
0.140
Why?
Mutation
7
2018
4443
0.140
Why?
Internet
3
2020
359
0.140
Why?
Income
1
2019
103
0.140
Why?
Liver Diseases
1
2001
250
0.140
Why?
Cytokines
2
2002
890
0.140
Why?
Immunohistochemistry
7
2012
1818
0.140
Why?
Interviews as Topic
1
2020
390
0.140
Why?
Colectomy
1
2000
211
0.140
Why?
B7-H1 Antigen
2
2018
333
0.140
Why?
Palliative Medicine
1
2018
11
0.140
Why?
Hypothyroidism
1
2001
299
0.140
Why?
Manuscripts as Topic
1
2018
4
0.140
Why?
Hospitals
3
2019
351
0.140
Why?
Carcinoma, Adenosquamous
1
1998
12
0.130
Why?
Risk Assessment
5
2014
2604
0.130
Why?
Antineoplastic Agents, Immunological
1
2020
238
0.130
Why?
Gene Amplification
1
2018
142
0.130
Why?
Janus Kinase 2
1
2018
59
0.130
Why?
Writing
1
2018
27
0.130
Why?
Precancerous Conditions
2
2009
221
0.130
Why?
Parenteral Nutrition
1
1998
63
0.130
Why?
Minimally Invasive Surgical Procedures
3
2012
317
0.130
Why?
Pyrrolidines
1
2018
61
0.130
Why?
Residence Characteristics
1
2019
240
0.130
Why?
Adrenal Gland Neoplasms
2
2003
85
0.130
Why?
Perioperative Care
1
2019
199
0.130
Why?
Transplantation, Heterologous
4
2003
375
0.130
Why?
Radiation, Ionizing
6
2011
123
0.130
Why?
Thinness
1
2017
49
0.130
Why?
Nitric Oxide Synthase
1
1997
124
0.120
Why?
Clinical Trials, Phase II as Topic
1
2017
168
0.120
Why?
Publishing
1
2018
97
0.120
Why?
Chicago
5
2020
1520
0.120
Why?
DNA
5
2012
1274
0.120
Why?
Interleukin-2
1
1997
246
0.120
Why?
Journal Impact Factor
1
2016
18
0.120
Why?
Nanostructures
1
2017
93
0.120
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1995
18
0.120
Why?
Hospitals, High-Volume
1
2016
53
0.110
Why?
Benchmarking
1
2016
86
0.110
Why?
Sulfonamides
1
2018
352
0.110
Why?
Chemokine CXCL10
1
2015
25
0.110
Why?
Tissue Preservation
1
2015
15
0.110
Why?
Viral Proteins
2
2007
252
0.110
Why?
Antibodies, Monoclonal
6
2014
1422
0.110
Why?
Hyperthermia, Induced
1
1995
77
0.110
Why?
Disease Progression
5
2012
1621
0.110
Why?
Pancreatic Fistula
1
2015
18
0.110
Why?
Diagnostic Imaging
3
2015
468
0.110
Why?
Hepatitis C
1
1997
186
0.110
Why?
Protein Kinase Inhibitors
2
2018
642
0.110
Why?
DNA Methylation
2
2018
735
0.110
Why?
Octreotide
1
2015
32
0.110
Why?
Drug Therapy
1
2015
67
0.110
Why?
Decision Making
1
2020
691
0.100
Why?
Teaching
2
2013
145
0.100
Why?
Surgeons
1
2019
336
0.100
Why?
Skin Neoplasms
2
2019
638
0.100
Why?
Dissent and Disputes
1
2014
28
0.100
Why?
Signal Transduction
5
2024
3642
0.100
Why?
Quality Improvement
2
2016
538
0.100
Why?
Pancreatitis, Chronic
1
2015
89
0.100
Why?
Pursuit, Smooth
1
1994
31
0.100
Why?
Self Care
1
2015
188
0.100
Why?
Universities
1
2015
166
0.100
Why?
Periodicals as Topic
1
2016
175
0.100
Why?
Cholangitis
2
2012
19
0.100
Why?
CD4 Antigens
5
2000
81
0.100
Why?
Cetuximab
1
2014
119
0.100
Why?
Tumor Suppressor Protein p53
5
2007
470
0.100
Why?
Graft Rejection
3
2011
1189
0.100
Why?
Cohort Studies
6
2017
3242
0.100
Why?
Data Collection
1
2015
376
0.100
Why?
Peritoneal Lavage
1
2013
12
0.100
Why?
Carcinoma, Non-Small-Cell Lung
3
2018
1177
0.100
Why?
Referral and Consultation
1
2016
419
0.100
Why?
Pediatrics
1
2018
422
0.100
Why?
Body Mass Index
1
2017
869
0.100
Why?
Enzyme-Linked Immunosorbent Assay
2
2011
374
0.090
Why?
Critical Care
1
2016
464
0.090
Why?
SEER Program
1
2014
252
0.090
Why?
Mastectomy, Segmental
1
1994
119
0.090
Why?
Preoperative Care
3
2017
420
0.090
Why?
History, 21st Century
1
2013
196
0.090
Why?
Incidence
6
2014
1798
0.090
Why?
Pilot Projects
4
2024
978
0.090
Why?
Interferon-alpha
3
2010
191
0.090
Why?
Geriatric Assessment
1
2014
193
0.090
Why?
Receptor, EphB4
1
2012
23
0.090
Why?
Biomedical Research
1
2018
477
0.090
Why?
Program Evaluation
3
2020
349
0.090
Why?
Precision Medicine
1
2017
512
0.090
Why?
Length of Stay
5
2017
889
0.090
Why?
Cues
1
1994
192
0.090
Why?
Sequence Deletion
3
2007
208
0.090
Why?
Urinary Bladder Neoplasms
1
2016
403
0.090
Why?
Portraits as Topic
1
2012
6
0.090
Why?
Lung
5
2012
1409
0.090
Why?
Registries
2
2015
1133
0.090
Why?
Heterografts
3
2018
121
0.090
Why?
Carcinoma, Lobular
1
2012
84
0.090
Why?
Carcinoma in Situ
1
1992
55
0.090
Why?
Islets of Langerhans
1
2015
570
0.090
Why?
Hemangioma, Cavernous
1
1992
66
0.080
Why?
Genomics
1
2017
914
0.080
Why?
Leadership
1
2013
163
0.080
Why?
Cadherins
1
2012
189
0.080
Why?
Maximum Tolerated Dose
1
2012
265
0.080
Why?
Intraoperative Period
1
2011
93
0.080
Why?
Urine
1
2011
91
0.080
Why?
Faculty, Medical
1
2013
197
0.080
Why?
Remission Induction
4
2001
764
0.080
Why?
Capecitabine
1
2011
103
0.080
Why?
Adolescent
11
2017
10168
0.080
Why?
CD8-Positive T-Lymphocytes
2
2016
701
0.080
Why?
MAP Kinase Kinase Kinases
2
2007
44
0.080
Why?
Patient Care Team
1
2014
318
0.080
Why?
Research Design
2
2013
652
0.080
Why?
Educational Measurement
2
2009
243
0.080
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
137
0.080
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2011
90
0.080
Why?
Oxidoreductases
1
2011
112
0.080
Why?
Bile Ducts, Extrahepatic
1
2010
12
0.080
Why?
Virus Replication
4
2007
292
0.080
Why?
Drug Administration Schedule
4
2017
837
0.080
Why?
Benzimidazoles
1
2011
120
0.080
Why?
Oligonucleotide Array Sequence Analysis
4
2011
700
0.080
Why?
Databases, Factual
4
2019
1102
0.080
Why?
Neoplasm, Residual
2
2015
205
0.080
Why?
Obesity
1
2017
1079
0.080
Why?
Cholestasis
1
1990
48
0.080
Why?
Immunologic Memory
1
2011
192
0.070
Why?
DNA Damage
3
2011
400
0.070
Why?
Digestive System Neoplasms
1
2009
20
0.070
Why?
Lymphocytes, Tumor-Infiltrating
1
2011
168
0.070
Why?
HIV Antibodies
3
1995
39
0.070
Why?
STAT1 Transcription Factor
1
2009
60
0.070
Why?
Feedback
1
2009
132
0.070
Why?
X-Ray Therapy
1
2008
7
0.070
Why?
Fibroma
1
1989
30
0.070
Why?
Triage
2
2020
150
0.070
Why?
Membrane Glycoproteins
1
2011
446
0.070
Why?
Neuroendocrine Tumors
1
2011
158
0.070
Why?
Transforming Growth Factor beta
1
2011
357
0.070
Why?
Treatment Failure
3
2012
300
0.070
Why?
Thoracoscopy
3
1998
21
0.070
Why?
Radiation-Sensitizing Agents
1
2008
99
0.070
Why?
Enzyme Inhibitors
1
2011
641
0.070
Why?
Genetic Testing
1
2012
610
0.070
Why?
Stilbenes
1
2007
26
0.070
Why?
Risk Factors
5
2025
6295
0.070
Why?
Interleukin-4
2
2002
136
0.070
Why?
Antibodies, Anti-Idiotypic
1
2007
45
0.070
Why?
Doxorubicin
2
2009
285
0.070
Why?
Lipid Droplets
1
2007
21
0.070
Why?
Proto-Oncogene Proteins c-kit
2
2007
80
0.060
Why?
Epitopes
5
2000
259
0.060
Why?
Ethics, Medical
1
2010
292
0.060
Why?
Child
9
2018
7771
0.060
Why?
Adenoviruses, Human
2
2012
41
0.060
Why?
Hypercalcemia
1
2007
60
0.060
Why?
Gene Expression Profiling
4
2018
1572
0.060
Why?
Necrosis
2
2007
225
0.060
Why?
Kaplan-Meier Estimate
2
2021
909
0.060
Why?
Parathyroid Neoplasms
1
2007
61
0.060
Why?
Mice, Inbred C57BL
5
2016
3628
0.060
Why?
Immunity, Cellular
1
2007
187
0.060
Why?
Common Bile Duct
2
1991
19
0.060
Why?
Blood Cells
1
2006
32
0.060
Why?
Veratrum Alkaloids
1
2006
9
0.060
Why?
Cell Movement
3
2020
821
0.060
Why?
Infusions, Intravenous
5
1995
403
0.060
Why?
Gene Expression
4
2015
1322
0.060
Why?
Paclitaxel
2
2006
484
0.060
Why?
Transplantation, Autologous
2
2019
398
0.060
Why?
Luminescent Proteins
2
2004
142
0.060
Why?
Drug Synergism
3
2017
317
0.060
Why?
eIF-2 Kinase
1
2006
52
0.060
Why?
Endothelium, Vascular
3
2004
440
0.060
Why?
Gallbladder
1
1985
33
0.060
Why?
Genetic Predisposition to Disease
2
2012
2588
0.060
Why?
Green Fluorescent Proteins
2
2004
310
0.060
Why?
Spleen
1
2006
375
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2006
100
0.060
Why?
Neutralization Tests
6
2001
74
0.060
Why?
Hedgehog Proteins
1
2006
104
0.060
Why?
Congresses as Topic
2
2016
125
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
123
0.060
Why?
Mice, SCID
2
2016
278
0.060
Why?
Rats, Inbred F344
3
1997
161
0.060
Why?
Endothelial Cells
2
2008
502
0.050
Why?
Polyethylene Glycols
2
2017
383
0.050
Why?
Transplantation, Homologous
2
2011
1029
0.050
Why?
Models, Biological
4
2006
1806
0.050
Why?
NF-kappa B
1
2007
424
0.050
Why?
Camptothecin
2
2017
198
0.050
Why?
Ethiodized Oil
1
2004
1
0.050
Why?
Glycine
1
2005
97
0.050
Why?
Cyclophosphamide
1
2005
285
0.050
Why?
Reproducibility of Results
2
2011
2799
0.050
Why?
Transfection
6
2007
884
0.050
Why?
Cytotoxins
1
2004
18
0.050
Why?
Logistic Models
2
2019
1276
0.050
Why?
Adjuvants, Immunologic
1
2005
177
0.050
Why?
Chemoembolization, Therapeutic
1
2004
40
0.050
Why?
Vascular Endothelial Growth Factor A
3
2018
402
0.050
Why?
Body Weight
3
2017
457
0.050
Why?
Antibiotics, Antineoplastic
1
2004
111
0.050
Why?
Neoplasms, Multiple Primary
2
1996
100
0.050
Why?
Internationality
2
2014
80
0.050
Why?
HIV Seropositivity
2
1995
49
0.050
Why?
Cell Adhesion
2
2020
421
0.050
Why?
Needs Assessment
2
2015
174
0.050
Why?
Behavior, Animal
1
2006
399
0.050
Why?
Etoposide
4
2007
207
0.050
Why?
Mitosis
1
2003
152
0.050
Why?
Staining and Labeling
1
2003
161
0.050
Why?
Young Adult
4
2017
7598
0.050
Why?
Erythropoietin
1
2003
90
0.050
Why?
Cell Transformation, Neoplastic
1
2005
466
0.050
Why?
Random Allocation
1
2003
312
0.050
Why?
Aortic Diseases
2
1994
88
0.050
Why?
Mortality
1
2003
160
0.050
Why?
Liver Cirrhosis
1
2004
290
0.050
Why?
External Fixators
2
1992
20
0.050
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2002
117
0.040
Why?
Diagnosis, Differential
2
2010
1571
0.040
Why?
beta Catenin
1
2024
269
0.040
Why?
Rats, Inbred ACI
1
2002
24
0.040
Why?
Transplantation, Isogeneic
1
2002
38
0.040
Why?
Tumor Burden
2
2015
330
0.040
Why?
Prostatic Neoplasms
2
2011
1846
0.040
Why?
Endothelial Growth Factors
1
2002
55
0.040
Why?
Lymphokines
1
2002
74
0.040
Why?
Analysis of Variance
2
2001
890
0.040
Why?
Rats, Inbred Lew
1
2002
219
0.040
Why?
Ethanol
1
2004
287
0.040
Why?
Guanine
1
2002
194
0.040
Why?
Drug Evaluation
2
1992
109
0.040
Why?
Up-Regulation
4
2005
742
0.040
Why?
Glioblastoma
1
2004
301
0.040
Why?
Recombinant Proteins
2
2010
994
0.040
Why?
Focal Nodular Hyperplasia
1
2001
10
0.040
Why?
Coumarins
1
2000
15
0.040
Why?
Interleukin-10
1
2002
167
0.040
Why?
Receptors, Chemokine
1
2000
30
0.040
Why?
Real-Time Polymerase Chain Reaction
2
2012
301
0.040
Why?
Hamartoma
1
2001
33
0.040
Why?
Hemangioma
1
2001
62
0.040
Why?
Cell Proliferation
2
2018
1801
0.040
Why?
Thyrotropin
2
2001
328
0.040
Why?
Catheter Ablation
1
2004
388
0.040
Why?
Cytoreduction Surgical Procedures
1
2021
105
0.040
Why?
Blood Loss, Surgical
1
2001
140
0.040
Why?
Illinois
2
2014
531
0.040
Why?
Mice, Transgenic
2
2016
1608
0.040
Why?
Polysaccharides
1
2000
101
0.040
Why?
Cysts
1
2001
100
0.040
Why?
Organizational Innovation
1
2020
42
0.040
Why?
Efficiency, Organizational
1
2020
55
0.040
Why?
Biomarkers
3
2003
2026
0.040
Why?
Patient Readmission
2
2014
441
0.040
Why?
Phenotype
3
2015
2673
0.040
Why?
Peripheral Nervous System Neoplasms
1
1999
15
0.040
Why?
Odds Ratio
1
2001
728
0.040
Why?
Spinal Nerve Roots
1
1999
21
0.040
Why?
Ampulla of Vater
1
2019
25
0.040
Why?
Retroperitoneal Neoplasms
1
1999
42
0.040
Why?
Neoplasm Invasiveness
3
2005
583
0.040
Why?
Healthy Lifestyle
1
2019
8
0.040
Why?
Neurilemmoma
1
1999
39
0.040
Why?
Health Services Accessibility
1
2024
548
0.040
Why?
Rats, Nude
1
1999
28
0.040
Why?
Genes, env
3
1993
8
0.040
Why?
DNA (Cytosine-5-)-Methyltransferase 1
1
2018
20
0.040
Why?
Pathology, Molecular
1
2019
36
0.040
Why?
Predictive Value of Tests
2
2014
1792
0.040
Why?
Cell Survival
3
2007
1018
0.040
Why?
Risk
1
2020
662
0.030
Why?
MCF-7 Cells
1
2018
123
0.030
Why?
Keratinocytes
1
1999
156
0.030
Why?
Adenoma
1
2001
262
0.030
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2018
63
0.030
Why?
Primary Prevention
1
2019
93
0.030
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
9
0.030
Why?
Equivalence Trials as Topic
1
2018
7
0.030
Why?
Training Support
1
2018
23
0.030
Why?
Neoplasm Proteins
1
2002
553
0.030
Why?
Interdisciplinary Studies
1
2018
19
0.030
Why?
Mutagenesis, Site-Directed
3
1993
273
0.030
Why?
Medical Staff, Hospital
2
2009
104
0.030
Why?
Laryngectomy
1
2018
26
0.030
Why?
Feasibility Studies
3
2013
818
0.030
Why?
Anorexia
2
2013
26
0.030
Why?
Molecular Targeted Therapy
1
2020
331
0.030
Why?
Nutrition Disorders
1
1998
16
0.030
Why?
Child, Preschool
4
2001
4053
0.030
Why?
Gene Knockdown Techniques
1
2018
256
0.030
Why?
Azacitidine
1
2018
152
0.030
Why?
Thoracic Neoplasms
1
1998
63
0.030
Why?
Filgrastim
1
2017
56
0.030
Why?
Injections, Intralesional
2
2012
22
0.030
Why?
Pregnancy Complications
1
2001
371
0.030
Why?
Oxygen
1
2003
777
0.030
Why?
Point Mutation
1
1998
236
0.030
Why?
Dose-Response Relationship, Drug
4
2006
1949
0.030
Why?
Receptor, Notch1
1
2018
106
0.030
Why?
Dihydroxyphenylalanine
1
2017
16
0.030
Why?
RNA, Long Noncoding
1
2018
133
0.030
Why?
HIV Envelope Protein gp41
2
1994
4
0.030
Why?
Enzyme Induction
1
1997
83
0.030
Why?
Perfusion
1
1999
272
0.030
Why?
Actins
1
2020
480
0.030
Why?
Radiotherapy Dosage
1
1998
478
0.030
Why?
Cyclins
1
1997
80
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
1997
76
0.030
Why?
Carcinoma, Lewis Lung
2
2011
25
0.030
Why?
Algorithms
2
2006
2005
0.030
Why?
cdc25 Phosphatases
1
2016
19
0.030
Why?
Reoperation
3
2014
730
0.030
Why?
Kidney Neoplasms
2
2002
556
0.030
Why?
Safety
2
2013
138
0.030
Why?
Kidney
1
2002
1126
0.030
Why?
Professional Autonomy
1
2016
44
0.030
Why?
Drug Carriers
1
2017
90
0.030
Why?
ErbB Receptors
1
1999
517
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
889
0.030
Why?
Overweight
1
2017
129
0.030
Why?
Chemokines
1
2016
79
0.030
Why?
Hepacivirus
1
1997
137
0.030
Why?
Pancreaticojejunostomy
1
1995
1
0.030
Why?
Laryngeal Neoplasms
1
1996
89
0.030
Why?
Pseudarthrosis
2
1992
20
0.030
Why?
Pancreatic Ducts
1
1995
37
0.030
Why?
Vero Cells
2
2006
100
0.030
Why?
Somatostatin
1
1995
61
0.030
Why?
North America
1
2016
211
0.030
Why?
Receptors, CXCR3
1
2015
13
0.030
Why?
Infant
2
2001
3368
0.030
Why?
Ipratropium
1
1995
18
0.030
Why?
Common Cold
1
1995
14
0.030
Why?
Pregnancy
2
2001
3286
0.030
Why?
Luminescent Measurements
1
2015
64
0.030
Why?
Practice Guidelines as Topic
2
2014
1116
0.030
Why?
Cell Differentiation
2
2016
1656
0.030
Why?
Leg
1
1995
145
0.030
Why?
Magnetic Resonance Imaging
3
2004
3622
0.030
Why?
Clinical Coding
1
2015
23
0.030
Why?
Lost to Follow-Up
1
2015
17
0.030
Why?
Cholesterol
1
2017
377
0.030
Why?
Infectious Disease Transmission, Vertical
1
1995
36
0.030
Why?
Alprostadil
1
1994
25
0.030
Why?
Personnel, Hospital
1
2015
32
0.030
Why?
Muromonab-CD3
1
1994
70
0.030
Why?
Base Sequence
3
2011
2224
0.030
Why?
Parenteral Nutrition, Total
1
1994
41
0.030
Why?
Flow Cytometry
1
2016
722
0.030
Why?
Age Factors
1
2019
1976
0.030
Why?
T-Lymphocytes
1
2002
1335
0.030
Why?
Graft Survival
2
1995
999
0.030
Why?
Embolism, Cholesterol
1
1994
2
0.030
Why?
Quality Control
1
2015
131
0.030
Why?
Blotting, Western
2
2007
779
0.030
Why?
Acquired Immunodeficiency Syndrome
1
1995
68
0.030
Why?
Administration, Oral
2
1995
677
0.030
Why?
Mice, Inbred NOD
1
2015
228
0.030
Why?
Popliteal Artery
1
1994
32
0.030
Why?
Enzyme Activation
2
2006
679
0.030
Why?
International Classification of Diseases
1
2015
77
0.030
Why?
Medical Records
1
2015
124
0.030
Why?
Relative Value Scales
1
2014
13
0.030
Why?
Arteriosclerosis
1
1994
107
0.030
Why?
Survivors
1
2015
211
0.030
Why?
Fovea Centralis
1
1994
19
0.030
Why?
Salvage Therapy
1
1995
241
0.030
Why?
Dumping Syndrome
1
2013
5
0.030
Why?
Avitaminosis
1
2013
5
0.030
Why?
Fixation, Ocular
1
1994
49
0.030
Why?
Femoral Artery
1
1994
96
0.030
Why?
Pregnancy Complications, Infectious
1
1995
100
0.030
Why?
Chronic Disease
1
1997
991
0.030
Why?
Pancreas
1
1995
269
0.020
Why?
Risk Adjustment
1
2014
45
0.020
Why?
Saccades
1
1994
79
0.020
Why?
Radiography, Interventional
1
1995
155
0.020
Why?
Caregivers
1
2015
200
0.020
Why?
Social Support
1
2015
246
0.020
Why?
Practice Patterns, Physicians'
1
2019
669
0.020
Why?
Multivariate Analysis
1
2016
1007
0.020
Why?
Cell Cycle
2
2006
519
0.020
Why?
Frail Elderly
1
2014
97
0.020
Why?
Competency-Based Education
1
2013
37
0.020
Why?
Robotic Surgical Procedures
1
2020
425
0.020
Why?
Solitary Pulmonary Nodule
1
1994
141
0.020
Why?
Radiography
2
1992
763
0.020
Why?
Bone Lengthening
1
1992
4
0.020
Why?
Motion Perception
1
1994
104
0.020
Why?
Aortic Aneurysm, Abdominal
1
1994
128
0.020
Why?
Hyperplasia
2
2009
149
0.020
Why?
Foot Deformities
1
1992
9
0.020
Why?
Contracture
1
1992
18
0.020
Why?
Umbilical Veins
2
2004
45
0.020
Why?
Diarrhea
1
2013
180
0.020
Why?
Multigene Family
2
2005
204
0.020
Why?
Population Surveillance
1
2014
218
0.020
Why?
Extracellular Space
1
1992
84
0.020
Why?
Gastric Mucosa
1
2012
73
0.020
Why?
Tissue Array Analysis
1
2012
135
0.020
Why?
DNA, Complementary
2
2004
380
0.020
Why?
Imaging, Three-Dimensional
1
2016
634
0.020
Why?
Immunoblotting
1
2012
273
0.020
Why?
Schistosomiasis japonica
1
1991
1
0.020
Why?
Hand Deformities, Congenital
1
1991
16
0.020
Why?
Antibodies, Helminth
1
1991
12
0.020
Why?
Gene Dosage
1
2012
216
0.020
Why?
Gastric Bypass
1
2013
121
0.020
Why?
Parotid Diseases
1
1991
5
0.020
Why?
Infarction
1
1991
25
0.020
Why?
Mesenteric Vascular Occlusion
1
1991
21
0.020
Why?
Prevalence
2
2007
1396
0.020
Why?
DNA Repair
2
2004
363
0.020
Why?
Thrombocytopenia
2
1990
194
0.020
Why?
Surgical Wound Infection
1
2014
252
0.020
Why?
Pancreatitis
1
2012
108
0.020
Why?
Cholestasis, Extrahepatic
1
1991
4
0.020
Why?
Vaccines, DNA
1
2011
19
0.020
Why?
Perioperative Period
1
2011
31
0.020
Why?
Neoplastic Cells, Circulating
1
1991
78
0.020
Why?
Immunization, Secondary
1
2011
42
0.020
Why?
Cells, Cultured
3
2004
2859
0.020
Why?
Tamoxifen
1
1992
177
0.020
Why?
DNA Breaks, Double-Stranded
1
2011
73
0.020
Why?
RNA, Messenger
1
1997
2076
0.020
Why?
National Cancer Institute (U.S.)
1
2011
77
0.020
Why?
Antigens, CD
1
2012
482
0.020
Why?
Cluster Analysis
1
2011
401
0.020
Why?
Fibroblasts
1
1994
767
0.020
Why?
Drug Therapy, Combination
2
2011
766
0.020
Why?
Leukopenia
1
1990
66
0.020
Why?
Family
1
2012
330
0.020
Why?
Hematemesis
1
2010
4
0.020
Why?
Creatinine
1
2011
315
0.020
Why?
Antimetabolites, Antineoplastic
1
2012
246
0.020
Why?
Databases, Genetic
1
2011
290
0.020
Why?
Education, Medical
1
2013
233
0.020
Why?
Glomerular Filtration Rate
1
2011
304
0.020
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2010
73
0.020
Why?
Models, Statistical
1
2014
602
0.020
Why?
Taxoids
1
2010
127
0.020
Why?
Alanine Transaminase
1
1990
74
0.020
Why?
Reference Standards
1
2010
147
0.020
Why?
Multicenter Studies as Topic
1
2010
195
0.020
Why?
Aspartate Aminotransferases
1
1990
74
0.020
Why?
Disease Management
1
2012
378
0.020
Why?
Bilirubin
1
1990
135
0.020
Why?
Forecasting
1
2011
298
0.020
Why?
RNA Polymerase II
1
1990
63
0.020
Why?
Surveys and Questionnaires
1
2018
3058
0.020
Why?
Sepsis
1
2014
402
0.020
Why?
Bile Duct Diseases
1
2009
23
0.020
Why?
Mastectomy
1
1992
277
0.020
Why?
Epithelial Cells
2
2005
710
0.020
Why?
Mucous Membrane
1
2009
83
0.020
Why?
Task Performance and Analysis
1
2009
91
0.020
Why?
Recombinant Fusion Proteins
2
2006
557
0.020
Why?
Statistics, Nonparametric
1
2009
304
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
22
0.020
Why?
Nuclear Proteins
2
2004
757
0.020
Why?
Etanercept
1
2008
37
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
40
0.020
Why?
Sensitivity and Specificity
1
2013
1946
0.020
Why?
Depression
1
2013
625
0.020
Why?
Binding Sites
3
2000
1162
0.020
Why?
Mammography
1
1992
505
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2008
85
0.020
Why?
HeLa Cells
2
2005
520
0.020
Why?
Probability
1
2009
356
0.020
Why?
Stem Cells
1
2011
399
0.020
Why?
Cell Line
4
1993
2484
0.020
Why?
Metaplasia
1
2007
40
0.020
Why?
Oncolytic Viruses
1
2007
20
0.020
Why?
Quinoxalines
1
2007
51
0.020
Why?
Acetylation
1
2007
151
0.020
Why?
CD4-Positive T-Lymphocytes
1
2011
507
0.020
Why?
Luciferases
1
2007
128
0.020
Why?
Immunotherapy, Adoptive
1
2011
336
0.020
Why?
Interferon-gamma
1
2009
478
0.020
Why?
Imidazoles
1
2007
142
0.020
Why?
Cross-Sectional Studies
1
2013
2077
0.020
Why?
Genetic Engineering
1
2007
102
0.020
Why?
Herpes Simplex
1
2007
79
0.020
Why?
Cellular Senescence
1
2007
113
0.020
Why?
Quality of Life
1
2015
1904
0.020
Why?
Sirtuins
1
2007
75
0.020
Why?
Parathyroidectomy
1
2007
88
0.020
Why?
Antineoplastic Protocols
1
2006
9
0.020
Why?
Stomatitis
1
2006
30
0.020
Why?
Genes, Neoplasm
1
2006
39
0.020
Why?
Academic Medical Centers
1
2009
416
0.020
Why?
Immunoglobulin G
1
2008
481
0.020
Why?
Endoscopy, Gastrointestinal
1
2007
171
0.020
Why?
Gene Deletion
1
2007
355
0.010
Why?
Parathyroid Hormone
1
2007
233
0.010
Why?
Mass Screening
1
1992
753
0.010
Why?
Quality of Health Care
1
2009
400
0.010
Why?
Genes, MDR
1
2005
7
0.010
Why?
Tumor Necrosis Factors
1
2005
14
0.010
Why?
Aging
1
2011
772
0.010
Why?
Genes, ras
1
2006
97
0.010
Why?
Wounds, Stab
1
1985
13
0.010
Why?
Cholecystectomy
1
1985
29
0.010
Why?
Flavonoids
1
2006
86
0.010
Why?
Cell Death
1
2006
258
0.010
Why?
Cornified Envelope Proline-Rich Proteins
1
2005
6
0.010
Why?
GATA6 Transcription Factor
1
2005
14
0.010
Why?
Injections, Intraperitoneal
1
2005
102
0.010
Why?
Gene Expression Regulation, Viral
1
2005
89
0.010
Why?
Abdominal Injuries
1
1985
51
0.010
Why?
Emergency Service, Hospital
1
2010
630
0.010
Why?
Palliative Care
1
2007
291
0.010
Why?
Rabbits
1
2005
582
0.010
Why?
Mice, Inbred C3H
1
2005
370
0.010
Why?
DNA, Viral
1
2005
238
0.010
Why?
Postoperative Period
1
2005
325
0.010
Why?
MAP Kinase Signaling System
1
2005
212
0.010
Why?
Integrin alphaV
1
2004
4
0.010
Why?
Integrin alphaVbeta3
1
2004
16
0.010
Why?
Infrared Rays
1
2004
19
0.010
Why?
DNA-Activated Protein Kinase
1
2004
16
0.010
Why?
Integrin beta1
1
2004
36
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2004
77
0.010
Why?
Wounds, Nonpenetrating
1
1985
119
0.010
Why?
Acetylcysteine
1
2004
73
0.010
Why?
Ataxia Telangiectasia Mutated Proteins
1
2004
65
0.010
Why?
Coculture Techniques
1
2004
175
0.010
Why?
Rad51 Recombinase
1
2004
81
0.010
Why?
Immunosuppressive Agents
1
2008
1021
0.010
Why?
Clinical Chemistry Tests
1
2003
11
0.010
Why?
Phosphorylation
1
2005
1148
0.010
Why?
Wounds, Gunshot
1
1985
154
0.010
Why?
Cell Division
1
2004
690
0.010
Why?
Pheochromocytoma
1
2003
54
0.010
Why?
Hypoxia-Inducible Factor 1
1
2003
44
0.010
Why?
Calcium
1
2007
1205
0.010
Why?
Neovascularization, Pathologic
1
2004
356
0.010
Why?
CHO Cells
1
2002
189
0.010
Why?
Plasmids
1
2003
275
0.010
Why?
Tumor Suppressor Proteins
1
2004
318
0.010
Why?
Cell Hypoxia
1
2003
191
0.010
Why?
Vascular Endothelial Growth Factors
1
2002
54
0.010
Why?
Liver
2
2001
1231
0.010
Why?
Recombination, Genetic
1
2004
424
0.010
Why?
Cathepsin L
1
2001
7
0.010
Why?
Cathepsins
1
2001
22
0.010
Why?
Cell Line, Transformed
1
2002
153
0.010
Why?
Cricetinae
1
2002
535
0.010
Why?
Urokinase-Type Plasminogen Activator
1
2001
49
0.010
Why?
Severity of Illness Index
1
2007
2025
0.010
Why?
Collagenases
1
2001
42
0.010
Why?
Cell Cycle Proteins
1
2004
420
0.010
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2003
177
0.010
Why?
Constriction
1
2001
26
0.010
Why?
Cysteine Endopeptidases
1
2001
89
0.010
Why?
Mouth Mucosa
1
2001
72
0.010
Why?
Bleomycin
1
1981
102
0.010
Why?
Adenovirus E1B Proteins
1
2001
1
0.010
Why?
Isocoumarins
1
2000
7
0.010
Why?
Mitogen-Activated Protein Kinases
1
2002
218
0.010
Why?
Radiation Tolerance
1
2002
179
0.010
Why?
Receptors, CCR5
1
2000
22
0.010
Why?
Methotrexate
1
1981
229
0.010
Why?
Viremia
1
2001
56
0.010
Why?
Proteoglycans
1
2000
76
0.010
Why?
Dose-Response Relationship, Radiation
1
2000
193
0.010
Why?
Receptors, CXCR4
1
2000
50
0.010
Why?
Laminin
1
2000
89
0.010
Why?
Drug Combinations
1
2000
202
0.010
Why?
Glycosylation
1
2000
142
0.010
Why?
Mastectomy, Radical
1
2000
10
0.010
Why?
Molecular Sequence Data
2
1996
2897
0.010
Why?
Down-Regulation
1
2001
529
0.010
Why?
Structure-Activity Relationship
1
2000
429
0.010
Why?
Proteins
1
2005
804
0.010
Why?
Chi-Square Distribution
1
2000
361
0.010
Why?
Kinetics
2
1993
1478
0.010
Why?
Collagen
1
2000
313
0.010
Why?
Tegafur
1
1998
17
0.010
Why?
Amino Acid Sequence
2
1992
2011
0.010
Why?
Uracil
1
1998
58
0.010
Why?
Nausea
1
1998
95
0.010
Why?
Anticoagulants
1
2001
486
0.010
Why?
Software
1
2001
698
0.010
Why?
Environmental Pollution
1
1996
13
0.010
Why?
Genetic Variation
2
1993
1460
0.010
Why?
Polymorphism, Genetic
1
1999
832
0.010
Why?
Drug Tolerance
1
1995
59
0.010
Why?
Methylene Blue
1
1995
19
0.010
Why?
Actuarial Analysis
1
1994
60
0.010
Why?
CD4 Lymphocyte Count
1
1995
75
0.010
Why?
Global Health
1
1996
216
0.010
Why?
Methylprednisolone
1
1994
65
0.010
Why?
Lymphocyte Count
1
1994
99
0.010
Why?
Food, Formulated
1
1994
25
0.010
Why?
Granuloma
1
1995
65
0.010
Why?
Burns, Chemical
1
1994
12
0.010
Why?
Nebulizers and Vaporizers
1
1995
63
0.010
Why?
Esophageal Perforation
1
1994
18
0.010
Why?
Contraindications
1
1994
66
0.010
Why?
Nasal Mucosa
1
1995
195
0.010
Why?
Biopsy
1
1998
1226
0.010
Why?
Energy Intake
1
1994
100
0.010
Why?
Patient Care Planning
1
1995
92
0.010
Why?
Azathioprine
1
1994
130
0.010
Why?
Binding, Competitive
1
1994
136
0.010
Why?
Topotecan
1
1994
47
0.010
Why?
Cyclosporine
1
1994
241
0.010
Why?
Antibody Specificity
1
1994
125
0.010
Why?
Esophagus
1
1994
113
0.010
Why?
Retroviridae
1
1994
74
0.010
Why?
Gene Transfer Techniques
1
1994
155
0.010
Why?
Clinical Protocols
1
1994
156
0.010
Why?
Diet
1
1996
472
0.010
Why?
Chloramphenicol O-Acetyltransferase
1
1992
26
0.010
Why?
Radioimmunoassay
1
1992
139
0.010
Why?
Bone Wires
1
1992
11
0.010
Why?
Immunoglobulin Idiotypes
1
1992
11
0.010
Why?
Achondroplasia
1
1992
9
0.010
Why?
Neoplasms, Second Primary
1
1995
244
0.010
Why?
Cloning, Molecular
1
1993
582
0.010
Why?
Immunoglobulin kappa-Chains
1
1992
60
0.010
Why?
Genes, Immunoglobulin
1
1992
62
0.010
Why?
Antigen-Antibody Complex
1
1992
89
0.010
Why?
Immunoglobulin Heavy Chains
1
1992
107
0.010
Why?
Immunoglobulin Variable Region
1
1992
87
0.010
Why?
Syndactyly
1
1991
14
0.010
Why?
Radiation Dosage
1
1993
233
0.010
Why?
Antigens, Helminth
1
1991
20
0.010
Why?
Philippines
1
1991
26
0.010
Why?
Gene Rearrangement
1
1992
175
0.010
Why?
Remission, Spontaneous
1
1991
45
0.010
Why?
Cross Reactions
1
1991
116
0.010
Why?
HLA-DR Antigens
1
1991
58
0.010
Why?
Ovum
1
1991
61
0.010
Why?
Edema
1
1991
68
0.010
Why?
Culture Techniques
1
1971
80
0.010
Why?
Fatty Acids, Nonesterified
1
1991
67
0.010
Why?
China
1
1991
283
0.010
Why?
Liver Regeneration
1
1971
33
0.010
Why?
Herpesvirus 4, Human
1
1991
127
0.010
Why?
Liver Function Tests
1
1991
95
0.010
Why?
Aorta, Thoracic
1
1991
154
0.000
Why?
Transcription Factor TFIIA
1
1990
2
0.000
Why?
Transcription Factor TFIID
1
1990
4
0.000
Why?
Templates, Genetic
1
1990
31
0.000
Why?
Ischemia
1
1991
263
0.000
Why?
Protein Binding
1
1993
1564
0.000
Why?
Ultrasonography
1
1991
722
0.000
Why?
Intestines
1
1991
442
0.000
Why?
Temperature
1
1990
446
0.000
Why?
Neutropenia
1
1981
211
0.000
Why?
Vesicular stomatitis Indiana virus
1
1971
16
0.000
Why?
Hypophysectomy
1
1971
26
0.000
Why?
Tritium
1
1971
114
0.000
Why?
Methods
1
1971
134
0.000
Why?
Thymidine
1
1971
58
0.000
Why?
Bromodeoxyuridine
1
1971
53
0.000
Why?
Haploidy
1
1971
30
0.000
Why?
Carbon Isotopes
1
1971
59
0.000
Why?
Prolactin
1
1971
90
0.000
Why?
Growth Hormone
1
1971
96
0.000
Why?
Leiomyosarcoma
1
1971
48
0.000
Why?
Interferons
1
1971
114
0.000
Why?
Hybridization, Genetic
1
1971
107
0.000
Why?
Mammary Neoplasms, Experimental
1
1971
130
0.000
Why?
Testicular Neoplasms
1
1971
126
0.000
Why?
Thyroxine
1
1971
411
0.000
Why?
Selection, Genetic
1
1971
572
0.000
Why?
Insulin
1
1971
1226
0.000
Why?
Ovarian Neoplasms
1
1971
829
0.000
Why?
Posner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (880)
Explore
_
Co-Authors (95)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_